Complement Inhibition in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Expert Opinion from Central Europe on Special Patient Populations.
Imre BodóIsmail AmineAna BobanHoria BumbeaAlexander Dmitrievich KulaginElena LukinaAgnieszka PiekarskaIrena Preloznik ZupanJuraj SokolJerzy WindygaJaroslav CermakPublished in: Advances in therapy (2023)
Implementation of these recommendations uniformly across healthcare institutions will promote the best use of complement inhibition in managing PNH, and has the potential to positively impact patient outcomes in Central Europe and worldwide.